Furthermore, preclinical bladder cancer models suggest inhibition of macrophage recruitment via blockage of CCL2 can lead to a reduction of lymph node metastases and increased survival after chemotherapy [40, 41]. This evidence concerns the gene CCL2 and urinary bladder carcinoma.